NYSE:A - Agilent Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $92.84
  • Forecasted Upside: -18.63 %
  • Number of Analysts: 24
  • Breakdown:
  • 0 Sell Ratings
  • 12 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$114.09
▼ -0.26 (-0.23%)
1 month | 3 months | 12 months
Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$92.84
▼ -18.63% Downside Potential
This price target is based on 24 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $92.84, with a high forecast of $132.00 and a low forecast of $30.70. The average price target represents a -18.63% upside from the last price of $114.09.
Buy
The current consensus among 24 investment analysts is to buy stock in Agilent Technologies. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 6 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 11 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 12 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 12 hold ratings
  • 0 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 12 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/25/2020UBS GroupUpgradeNeutral ➝ Buy$103.00 ➝ $132.00Low
i
11/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$110.00 ➝ $125.00High
i
11/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$105.00 ➝ $120.00High
i
11/24/2020Robert W. BairdBoost Price TargetOutperform$104.00 ➝ $118.00High
i
11/24/2020SVB LeerinkBoost Price TargetOutperform$100.00 ➝ $120.00High
i
Rating by P. Souda at SVB Leerink LLC
11/17/2020Cleveland ResearchUpgradeNeutral ➝ BuyLow
i
11/9/2020KeyCorpInitiated CoverageOverweight$130.00High
i
11/9/2020HSBCUpgradeHold ➝ Buy$30.70High
i
11/3/2020Morgan StanleyUpgradeEqual Weight ➝ OverweightLow
i
9/30/2020Atlantic SecuritiesInitiated CoverageNeutral$105.00Low
i
8/25/2020Stifel NicolausLower Price TargetHold$39.00 ➝ $37.00Low
i
8/19/2020Bank of AmericaBoost Price TargetNeutral$99.00 ➝ $103.00Low
i
8/19/2020Stifel NicolausBoost Price TargetHold$85.00 ➝ $100.00Medium
i
8/19/2020Jefferies Financial GroupBoost Price TargetBuy$95.00 ➝ $110.00Medium
i
8/19/2020SVB LeerinkBoost Price TargetOutperform$95.00 ➝ $100.00High
i
Rating by P. Souda at SVB Leerink LLC
8/19/2020Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $104.00High
i
8/19/2020Needham & Company LLCReiterated RatingHoldHigh
i
8/19/2020CitigroupBoost Price TargetNeutral$85.00 ➝ $100.00High
i
8/19/2020Wells Fargo & CompanyReiterated RatingOverweight$100.00 ➝ $105.00High
i
7/27/2020Credit Suisse GroupBoost Price TargetNeutral$53.00 ➝ $54.00Medium
i
7/27/2020Canaccord GenuityBoost Price TargetHold$56.00 ➝ $60.00High
i
7/20/2020Bank of AmericaBoost Price TargetNeutral$88.00 ➝ $99.00High
i
7/13/2020The Goldman Sachs GroupInitiated CoverageNeutralHigh
i
7/2/2020Canaccord GenuityInitiated CoverageHold$56.00Medium
i
7/1/2020The Goldman Sachs GroupReiterated RatingBuy ➝ NeutralMedium
i
5/22/2020CfraLower Price TargetHold$89.00 ➝ $85.00Low
i
5/22/2020Bank of AmericaBoost Price TargetNeutral$74.00 ➝ $88.00Low
i
5/22/2020UBS GroupBoost Price TargetNeutral$84.00 ➝ $87.00Medium
i
5/22/2020CowenBoost Price TargetOutperform$80.00 ➝ $95.00Medium
i
5/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$82.00 ➝ $95.00Low
i
5/22/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00Low
i
4/28/2020Royal Bank of CanadaInitiated CoverageSector PerformLow
i
4/28/2020UBS GroupLower Price TargetNeutral$90.00 ➝ $84.00Low
i
4/16/2020SunTrust BanksLower Price TargetHold$90.00 ➝ $75.00Low
i
4/2/2020Stifel NicolausLower Price TargetHold$85.00 ➝ $73.00Medium
i
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$100.00 ➝ $82.00Low
i
3/26/2020BarclaysLower Price TargetEqual Weight$85.00 ➝ $76.00Low
i
Rating by Jack Meehan at Barclays PLC
3/20/2020CitigroupLower Price TargetNeutral$85.00 ➝ $75.00Medium
i
2/24/2020Needham & Company LLCDowngradeBuy ➝ Hold$85.00High
i
2/21/2020CfraLower Price TargetHold$60.00 ➝ $57.00Low
i
2/19/2020Piper SandlerBoost Price TargetOverweight$86.00 ➝ $96.00Medium
i
2/19/2020UBS GroupBoost Price TargetBuy ➝ Neutral$87.00 ➝ $90.00High
i
Rating by Daniel Brennan at UBS Group AG
2/12/2020HSBCUpgradeHold ➝ BuyLow
i
1/28/2020UBS GroupReiterated RatingBuyLow
i
Rating by Daniel Brennan at UBS Group AG
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$100.00 ➝ $100.00Medium
i
1/6/2020CitigroupInitiated CoverageNeutral$85.00Low
i
1/3/2020Needham & Company LLCInitiated CoverageBuy$77.00Medium
i
11/26/2019UBS GroupBoost Price TargetNeutral$82.00 ➝ $87.00Low
i
Rating by Daniel Brennan at UBS Group AG
11/26/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00 ➝ $90.00High
i
11/26/2019Needham & Company LLCReiterated RatingBuy$92.00 ➝ $85.00High
i
11/14/2019Stifel NicolausInitiated CoverageHold$85.00High
i
10/18/2019UBS GroupDowngradeBuy ➝ Neutral$82.00Medium
i
10/9/2019BarclaysLower Price TargetEqual Weight$78.00 ➝ $76.00Low
i
Rating by Jack Meehan at Barclays PLC
8/19/2019Needham & Company LLCBoost Price TargetBuy$92.00Low
i
8/15/2019Robert W. BairdReiterated RatingOutperform$79.00 ➝ $82.00High
i
8/15/2019Piper Jaffray CompaniesBoost Price TargetOverweight$83.00 ➝ $86.00High
i
7/16/2019Bank of AmericaDowngradeBuy ➝ Neutral$76.00Low
i
7/15/2019BarclaysDowngradeOverweight ➝ Equal Weight$86.00 ➝ $78.00Low
i
6/11/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$83.00Low
i
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
i
5/15/2019Bank of AmericaLower Price TargetBuy$88.00 ➝ $82.00High
i
5/15/2019Deutsche Bank AktiengesellschaftLower Price TargetBuy$90.00 ➝ $85.00High
i
5/15/2019BarclaysLower Price TargetOverweight$88.00 ➝ $86.00High
i
3/26/2019CowenBoost Price TargetOutperform ➝ Outperform$80.00 ➝ $90.00Low
i
3/15/2019UBS GroupInitiated CoverageBuy ➝ Buy$92.00Low
i
2/25/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$77.00 ➝ $88.00Low
i
2/21/2019Janney Montgomery ScottReiterated RatingOverweight ➝ Buy$80.00 ➝ $90.00Low
i
2/21/2019Bank of AmericaReiterated RatingBuy ➝ Buy$78.00 ➝ $87.00Low
i
2/21/2019BarclaysBoost Price TargetOverweight ➝ Overweight$80.00 ➝ $83.00Low
i
2/21/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy$90.00Low
i
2/21/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00Medium
i
2/20/2019Robert W. BairdReiterated RatingBuy$77.00 ➝ $82.00High
i
2/12/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$80.00 ➝ $85.00Low
i
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$77.00High
i
12/31/2018Alembic Global AdvisorsDowngradeHoldMedium
i
Rating by Hassan Ahmed at Alembic Global Advisors
11/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$86.00 ➝ $89.00Medium
i
11/12/2018Cleveland ResearchDowngradeBuy ➝ NeutralMedium
i
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$84.00 ➝ $86.00High
i
9/18/2018The Goldman Sachs GroupReiterated RatingBuy$77.00 ➝ $82.00Low
i
9/17/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
i
8/15/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$77.00 ➝ $80.00Medium
i
8/15/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$83.00 ➝ $84.00Medium
i
5/15/2018CowenUpgradeMarket Perform ➝ OutperformHigh
i
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$95.00 ➝ $91.00Low
i
4/9/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
i
4/2/2018Morgan StanleyBoost Price TargetOverweight$90.00 ➝ $95.00High
i
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$75.00 ➝ $80.00Low
i
1/18/2018Robert W. BairdReiterated RatingBuy$76.00Medium
i
1/8/2018BarclaysReiterated RatingBuy$74.00Low
i
1/3/2018Evercore ISIInitiated CoverageOutperform$75.00Medium
i
11/24/2017Robert W. BairdReiterated RatingBuy$72.00N/A
i
11/22/2017CowenReiterated RatingHold$70.00N/A
i
11/21/2017BarclaysBoost Price TargetOverweight$67.00 ➝ $71.00N/A
i
11/21/2017JPMorgan Chase & Co.Boost Price TargetOverweight$75.00N/A
i
11/21/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$75.00N/A
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
11/14/2017Morgan StanleyReiterated RatingOverweightN/A
i
10/20/2017Robert W. BairdReiterated RatingBuy$70.00N/A
i
9/28/2017CowenReiterated RatingHold$65.00Low
i
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$68.00Low
i
8/16/2017Bank of AmericaBoost Price TargetEqual Weight$66.00 ➝ $68.00Medium
i
Rating by Derik De Bruin at Bank of America Co.
8/16/2017Morgan StanleyReiterated RatingOverweightMedium
i
8/16/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$66.00 ➝ $68.00Medium
i
Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
8/16/2017Janney Montgomery ScottBoost Price TargetBuy$65.00 ➝ $70.00Medium
i
8/16/2017JPMorgan Chase & Co.Reiterated RatingOverweight$70.00Low
i
8/15/2017Bank of AmericaReiterated RatingEqual WeightMedium
i
Rating by Derik De Bruin at Bank of America Co.
8/9/2017Jefferies Financial GroupReiterated RatingBuy$66.00High
i
7/19/2017BarclaysReiterated RatingBuy$67.00Low
i
7/12/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$42.92 ➝ $60.73Low
i
7/10/2017Morgan StanleyReiterated RatingOverweightLow
i
6/22/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$66.00Medium
i
5/24/2017Morgan StanleyBoost Price TargetOverweight$65.00 ➝ $70.00Low
i
5/24/2017BTIG ResearchBoost Price TargetBuy$57.00 ➝ $65.00Low
i
5/24/2017Robert W. BairdBoost Price TargetOutperform$57.00 ➝ $62.00Low
i
5/23/2017Jefferies Financial GroupBoost Price TargetBuy$59.00 ➝ $66.00Low
i
5/23/2017CowenBoost Price TargetMarket Perform$53.00 ➝ $62.00Medium
i
5/22/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$58.00 ➝ $62.00Low
i
4/2/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$56.00 ➝ $58.00Low
i
3/17/2017Jefferies Financial GroupReiterated RatingBuy$59.00Low
i
3/15/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$62.00High
i
2/15/2017UBS GroupBoost Price TargetNeutral$48.00 ➝ $50.00N/A
i
2/13/2017Janney Montgomery ScottBoost Price TargetBuy$55.00 ➝ $60.00N/A
i
1/18/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$54.00N/A
i
1/4/2017CowenDowngradeOutperform ➝ Market Perform$51.00N/A
i
1/4/2017BarclaysUpgradeEqual Weight ➝ Overweight$48.00 ➝ $51.00N/A
i
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/A
i
12/4/2016BTIG ResearchReiterated RatingBuy$55.00N/A
i
12/4/2016UBS GroupReiterated RatingNeutral$45.00 ➝ $48.00N/A
i
11/16/2016BTIG ResearchReiterated RatingBuyN/A
i
11/16/2016UBS GroupReiterated RatingHold$48.00N/A
i
11/10/2016SVB LeerinkInitiated CoverageOutperform$53.00N/A
i
Rating by Dan Leonard at SVB Leerink LLC
10/7/2016Bank of AmericaSet Price TargetBuy$51.00N/A
i
Rating by Derik De Bruin at Bank of America Co.
9/7/2016The Goldman Sachs GroupReiterated RatingBuy$53.00N/A
i
8/18/2016Morgan StanleySet Price TargetHold$47.00N/A
i
Rating by Steve Beuchaw at Morgan Stanley
8/18/2016Robert W. BairdBoost Price TargetOutperform$48.00 ➝ $52.00N/A
i
8/18/2016The Goldman Sachs GroupReiterated RatingBuy$50.00N/A
i
8/18/2016Evercore ISIBoost Price TargetBuy$50.00 ➝ $53.00N/A
i
Rating by Ross Muken at Evercore ISI
8/18/2016CowenBoost Price TargetOutperform$49.00 ➝ $51.00N/A
i
Rating by Doug Schenkel at Cowen Inc
8/18/2016BTIG ResearchReiterated RatingBuy$55.00N/A
i
Rating by Dane Leone at BTIG Research
7/22/2016BTIG ResearchInitiated CoverageBuy$55.00N/A
i
Rating by Dane Leone at BTIG Research
6/30/2016SVB LeerinkReiterated RatingOutperform$51.00N/A
i
Rating by Dan Leonard at SVB Leerink LLC
6/8/2016BarclaysReiterated RatingHold$45.00N/A
i
6/1/2016Deutsche Bank AktiengesellschaftInitiated CoverageHoldN/A
i
Rating by Shawn Bevec at Deutsche Bank Aktiengesellschaft
5/29/2016BTIG ResearchReiterated RatingBuy$50.00N/A
i
Rating by Dane Leone at BTIG Research
5/26/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Dan Leonard at SVB Leerink LLC
5/26/2016CowenReiterated RatingOutperform$47.00 ➝ $49.00N/A
i
Rating by Doug Schenkel at Cowen Inc
5/17/2016BTIG ResearchUpgradeBuy$50.00N/A
i
Rating by Dane Leone at BTIG Research
5/17/2016Morgan StanleyReiterated RatingHold$44.00 ➝ $47.00N/A
i
Rating by Steve Beuchaw at Morgan Stanley
5/17/2016Wells Fargo & CompanyReiterated RatingHold$43.50 ➝ $44.50N/A
i
Rating by Tim Evans at Wells Fargo & Company
5/17/2016SVB LeerinkReiterated RatingBuy$44.00 ➝ $51.00N/A
i
Rating by Dan Leonard at SVB Leerink LLC
5/17/2016Evercore ISIReiterated RatingBuy$43.00 ➝ $48.00N/A
i
5/17/2016BarclaysBoost Price TargetEqual Weight$42.00 ➝ $45.00N/A
i
5/17/2016Jefferies Financial GroupReiterated RatingBuy$46.00 ➝ $51.00N/A
i
5/11/2016The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$47.00 ➝ $49.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
4/14/2016UBS GroupInitiated CoverageHold$45.00N/A
i
Rating by Michael Briest at UBS Group AG
3/24/2016UBS GroupReiterated RatingHoldN/A
i
Rating by Jon Groberg at UBS Group AG
3/23/2016The Goldman Sachs GroupBoost Price Target$47.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
3/8/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Dan Leonard at SVB Leerink LLC
3/8/2016BTIG ResearchReiterated RatingBuy$50.00N/A
i
Rating by Dane Leone at BTIG Research
2/17/2016The Goldman Sachs GroupLower Price TargetBuy$46.00 ➝ $45.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
2/17/2016Evercore ISILower Price TargetBuy$46.50 ➝ $42.00N/A
i
2/17/2016Deutsche Bank AktiengesellschaftReiterated RatingNeutral ➝ Hold$42.00 ➝ $39.00N/A
i
2/17/2016CowenLower Price TargetOutperform$46.00 ➝ $44.00N/A
i
Rating by Doug Schenkel at Cowen Inc
2/17/2016BarclaysLower Price TargetEqual Weight$44.00 ➝ $42.00N/A
i
2/17/2016Bank of AmericaReiterated RatingEqual Weight$44.00 ➝ $42.00N/A
i
2/17/2016Robert W. BairdReiterated RatingOutperform$48.00 ➝ $46.00N/A
i
Rating by Jeff Elliott at Robert W. Baird
2/17/2016BTIG ResearchReiterated RatingBuy$50.00N/A
i
1/7/2016BarclaysBoost Price TargetEqual Weight$41.00 ➝ $44.00N/A
i
1/6/2016Deutsche Bank AktiengesellschaftInitiated CoverageHold$42.00N/A
i
12/9/2015Robert W. BairdUpgradeNeutral ➝ Outperform$45.00 ➝ $48.00N/A
i
12/8/2015The Goldman Sachs GroupUpgradeNeutral ➝ Buy$9.00 ➝ $48.00N/A
i
(Data available from 11/29/2015 forward)
Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was founded in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $114.09
$112.94
$114.98

50 Day Range

MA: $107.77
$101.66
$114.68

52 Week Range

Now: $114.09
$61.13
$118.96

Volume

983,723 shs

Average Volume

1,938,007 shs

Market Capitalization

$35.18 billion

P/E Ratio

49.60

Dividend Yield

0.63%

Beta

1.02